Cabergoline vs Bromocriptine for High Prolactin Levels
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial compares two medications, cabergoline and bromocriptine, to see which works better for women with high prolactin levels (hyperprolactinemia). It aims to find a more effective treatment to help manage this condition, which can affect fertility and menstrual cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women between 18 and 45 years old
- Diagnosed with high prolactin levels, with or without a pituitary tumor
- Willing to use effective birth control during the study
- No prior treatment with cabergoline or radiation therapy
- No allergy to ergot medications (like bromocriptine)
- Must be able to attend regular follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a higher dose of the drug cabergoline to see if it works better for small prolactin-secreting tumors (microprolactinomas) in premenopausal women who have not been treated before. It aims to find a safe and effective way to lower high prolactin levels and shrink the tumor.
This trial tests if cabergoline can help reduce high prolactin levels caused by antipsychotic medications in people with schizophrenia. It may be an option if you have symptoms like breast tenderness, milk production, or sexual side effects.
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
This trial compares medicine (bromocriptine) and surgery for people with a certain type of pituitary tumor (prolactinoma) that has not spread too far. It aims to see which approach works best and is safest for you.
This trial tests if cabergoline, a medicine, can help shrink nonfunctioning pituitary adenomas (benign tumors on the pituitary gland that don't produce excess hormones). It may be an option for people who have not had prior radiation or surgery, and whose tumors are at least 0.5 cm in size.
This study tests if adding cabergoline to letrozole works better than letrozole alone to help women with PCOS ovulate. It may help participants who have not had success with standard treatments.
Hear when a new Hyperprolactinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.